广东丸美生物技术股份有限公司 2025年半年度权益分派实施公告

Core Points - The company's profit distribution plan was approved at the first extraordinary general meeting of shareholders on September 19, 2025 [1] - The distribution will be based on a total share capital of 401,000,000 shares, with a cash dividend of 0.25 RMB per share, totaling 100,250,000 RMB [2] - The cash dividends will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the registration date [1][2] Distribution Plan - The cash dividend of 0.25 RMB per share is inclusive of tax, and the total cash dividend distribution amounts to 100,250,000 RMB [2] - The distribution will not include stock dividends or capital increases [2] - Shareholders who hold shares for more than one year will be exempt from individual income tax on the dividend, while those holding for one year or less will have tax withheld upon transfer [3] Taxation Details - Individual shareholders holding shares for less than one month will incur a 20% tax on dividends, while those holding for one month to one year will incur a 10% tax [3] - For qualified foreign institutional investors (QFII), a 10% corporate income tax will be withheld, resulting in a net dividend of 0.225 RMB per share [4] - Hong Kong investors through the Stock Connect will also face a 10% withholding tax, leading to a net dividend of 0.225 RMB per share [4] Contact Information - For inquiries regarding the profit distribution, shareholders can contact the board office at 020-66378685 [5]